May 19, 2025 May 19, 2025Categories Trial ResultsTop trial results of 2024: A year of major progress in cancer treatmentSeven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
September 26, 2024 September 26, 2024Categories Trial ResultsTrial Results: How one patient’s role in an ECOG-ACRIN study for acute lymphocytic leukemia brought a cancer-free diagnosis and FDA approvalAdding immunotherapy to standard chemotherapy keeps most patients with B-cell acute lymphoblastic leukemia in remission and improves their survival
January 5, 2023 January 5, 2023Categories Trial ResultsTrial Results: A recent ECOG-ACRIN study finds excellent results for patients with acute lymphoblastic leukemia (ALL)Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival
June 28, 2022 June 28, 2022Categories New TrialsNow Enrolling: The EA9213 clinical trial is testing a new treatment for patients with T-cell acute lymphoblastic leukemiaThis trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment